PORTAGE BIOTECH INC
(NASDAQ: PRTG)

Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

0.596

+0.046 (+8.36%)
Range - - -   (-%)
Open -
Previous Close 0.550
Bid Price 3.230
Bid Volume 12
Ask Price 3.240
Ask Volume 9
Volume 18,160
Value -
Remark
Delayed prices. Updated at 19 Mar 2024 03:59.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis